-
1 Comment
Medicure Inc is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Medicure Inc's total revenue sank by 35.7% to $4M since the same quarter in the previous year.
Its net income has dropped by 74.8% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 107.2% to $742K since the same quarter in the previous year.
Based on the above factors, Medicure Inc gets an overall score of 2/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | F |
CurrencyCode | EUR |
ISIN | CA58469E4085 |
Beta | 0.85 |
---|---|
Market Cap | 8M |
PE Ratio | None |
Target Price | None |
Dividend Yield | None |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NGQ1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025